Triglycerides, fasting glucose, and inflammatory markers frequently improve before significant weight loss, reflecting tirzepatide's metabolic benefits independent of fat reduction
Research on GLP-1 receptor agonists shows that losing 10 to 15% of body weight can reduce the Apnea-Hypopnea Index (AHI) by 30 to 50%
Currently, only a limited number of in vitro studies have investigated the effects of medical ozone on stem cell behaviour, and no in vivo studies are available
However, both influence body composition and metabolic function, meaning their combined effect on weight loss, muscle retention, and energy expenditure requires careful coordination with your prescribing physician
How and when you apply it is as important as the product itself